Cell-Based Assays World Industry and Market 2018-2028 - Visiongain Report

LONDON, September 19, 2018 /PRNewswire/ --

Drug Discovery, Basic Research, Predictive Technology, Instrument, Consumables, Software, Services, Reagents, Assay Kits, Microplates, Cell Lines, Probes & Labels, Pharma & Biotech Companies, Academic Institutes, CROs

The revenue of the cell-based assays market in 2017 is estimated at $13bn and is expected to grow at a CAGR of 9.2% in the first half of the forecast period. Visiongain estimated that the consumables and services segments accounted for 74.26% of the market.

     (Logo: https://mma.prnewswire.com/media/523989/Visiongain_Logo.jpg )

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 241-page report you will receive 85 tables and 103 figures- all unavailable elsewhere.

The 241-page report provides clear detailed insight into the cell-based assays market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope 

• Cell-based Assays market forecasts from 2018-2028

• Cell-Based Assays Market by Product Type:
• Instrument
• Consumables
• Software
• Services
• Reagents
• Assay Kits
• Microplates
• Cell Lines
• Probes & Labels

• Cell-Based Assays Market by Application:
• Drug Discovery
• Basic Research
• Predictive Technology

• Cell-based Assays Market by End-User:
• Pharma & Biotech Companies
• Academic Institutes
• CROs

• This report provides individual revenue forecasts to 2028 for these national markets:
• US
• Japan
• Germany
• UK
• France
• Spain
• Italy
• China
• India
• Russia
• Brazil

• Our study includes SWOT and STEP analysis of the cell-based assays market.

• Our study discusses the selected leading companies that are the major players in the cell-based assays market:
• BD (Becton, Dickinson and Company)
• BioAgilytix Labs
• BioVision
• Cell Assay Innovations, Inc.
• Charles River Laboratories International
• CYTOO SA
• DiscoverX
• GE Healthcare
• InSphero
• Marin Biological Laboratories
• Molecular Devices
• Perkin Elmer
• Pharmaceutical Product Development
• Porsolt
• Promega
• ProQinase GmbH
• QGel
• SGS Group, Inc.
• Thermo Fisher Scientific (and Affymetrix acquisition)

• This report also discusses technology, trends and future outlook of the cell-based assays industry

Visiongain's study is intended for anyone requiring commercial analyses for the cell-based assays market. You find data, trends and predictions.

Buy our report today Cell-Based Assays World Industry and Market 2018-2028: Drug Discovery, Basic Research, Predictive Technology, Instrument, Consumables, Software, Services, Reagents, Assay Kits, Microplates, Cell Lines, Probes & Labels, Pharma & Biotech Companies, Academic Institutes, CROs.

To request a report overview of this report please contact Sara Peerun at sara.peerun@visiongain.com or refer to our website: https://www.visiongain.com/report/cell-based-assays-world-industry-and-market-2018-2028/

Abcam
Accuri Cytometers, Inc.
Affymetrix, Inc.
Agilent Technologies
Applied Biosystems
Ascendance Biotechnology
AstraZeneca
ATCC
AXAM
Axiogenesis AG
B'SYS GmbH
BASF
Bayer
Becton, Dickinson and Company
Becton Dickinson Asia Limited
Becton Dickinson Biosciences
BioAgilytix Labs
BioCity
Biocroi
Biofungitek
BioIVT
Biotechnology Industry Research Assistance Council (BIRAC)
BioVision, Inc.
BMG LABTECH GmbH
C.R. Bard
Caliper Life Sciences, Inc.
Cambridge Research & Instrumentation, Inc.
Cell Assay Innovations (CAI)
Cell Biolabs
Charles River Germany GmbH & Co. KG
Charles River Holdings LLC
Charles River Laboratories
Charles River Laboratories International, Inc.
Charles River Laboratories, Inc.
Charles River Nederland BV
Charles River UK Limited
Cisbio Bioassays
Cohesive Technologies Inc.
Contextual Genomics
CYTOO SA
Daiichi Sankyo Company Limited
Danaher Corporation
Department of Biotechnology (DBT)
DiscoverX
Dr. Reddy's Laboratories
Draconis Pharma
Eurofins Scientific S.E.
EUROIMMUN US Inc.
Food and Drug Administration (FDA)
Fisher Scientific
FLUOFARMA
Foundation Top Institute Pharma
Fulcrum Therapeutics
GE Healthcare
GE Healthcare AS
GE Healthcare Bio-Sciences AB
GE Healthcare BVBA
GE Healthcare European Holdings SARL
GE Healthcare Japan Corporation
GE Healthcare USA Holding LLC
General Electric Company
GIMDx, Inc.
Guangzhou Improve Medical Instruments
HD Biosciences Co., Ltd.
Helsinki Institute of Life Science
Icagen, Inc.
Idengene SA
IncellDx, Inc
Indian Institute of Chemical Technology (IICT)
Innoprot
InSphero AG
IntelliCyt
Interchim
Invitrogen
Janssen
Jubilant Biosys
Labcyte Inc.
Lead Discovery Centre GmbH
Likarda
Luxcel Biosciences Ltd
Marin Biologic Laboratories
Mayflower Biosciences
Merck KGaA
Metrion Biosciences Ltd
Molecular Devices, LLC
NanoString Technologies, Inc.
Ncardia
NEOMED Institute
Netherlands Cancer Institute
Neuron BioServices
NovaScreen Biosciences Corporation
NovaWave Technologies, Inc.
On Target Co., Ltd
Oncotest
Pelago Bioscience
Perkin Elmer Inc.
Phadia GmbH
Pharmaceutical Product Development (PPD)
Pharmaceutical Product Development, LLC.
Phenomics Discovery Initiative (PDi)
Pluriomics B.V.
Porsolt
Porsolt and Fluofarma acquisition
Premas Lifescience
Promega Corporation
ProQinase GmbH
QGel SA.
Riken Genesis
Russian Federation
Sanofi
Science Exchange
SGS Australia
SGS Belgium NV
SGS Central America S.A.
SGS Group
SGS North America Inc.
Skolkovo Foundation
StemTek therapeutics
Sygnature Discovery
Syncom
Sysmex Corporation
Systems and Reagents Inc.
Takeda Pharmaceutical Company Limited
Tecan Group Ltd.
The Structural Genomics Consortium
Thermo Electron A/S
Thermo Fisher Scientific (and Affymetrix acquisition)
Thermo Fisher Scientific Operating Company LLC
Thermo Fisher Scientific Senior Financing LLC
Thermo Scientific
Tufts Center for the Study of Drug Development
UCB
Unity Lab Services
Valneva SE
VitoTag Biosciences
Xenogen Corporation
ZF BioLabs
ZF Biotox

List of Organisations mentioned in the report
All India Institute of Medical Sciences (AIIMS)
American Society of Cell Biology (ASCB)
AMR Centre (AMRC)
Association of Research-Based Pharmaceutical Companies
Biotechnology Industry Research Assistance Council (BIRAC)
Department of Biotechnology (DBT)
Foundation Top Institute Pharma
Helsinki Institute of Life Science
Imperial College London
Indian Institute of Chemical Technology (IICT)
Innovative Medicines Initiative (IMI)
nstitute for Chemical Sciences in Rennes
Institute for In Vitro Sciences, Inc. (IIVS)
Institute for Molecular Medicine Finland (FIMM)
Karolinska Institutet
Medical Research Council (MRC) Centre for Regenerative Medicine (CRM)
Memorial Sloan Kettering Cancer Center (MSK)
National Health Service (NHS)
National Phenotypic Screening Centre (NPSC)
NEOMED Institute
Netherlands Cancer Institute
Oxford University
Pharmaceutical Research and Manufacturers of America (PhRMA)
Phenomics Discovery Initiative (PDi)
Russian Federation
Science Exchange
Skolkovo Foundation
Tufts Center for the Study of Drug Development
Unity Lab Services
University of Dundee
University of Edinburgh
University of Helsinki
University of Oxford
World Health Organization (WHO)

To see a report overview please e-mail Sara Peerun on sara.peerun@visiongain.com